Hepatic IPMK deficiency worsened hepatic steatosis, elevated serum ALT and AST levels, and expression of inflammatory genes in mice fed MCDD, suggesting a role as a molecular mediator in the effect of TRF in NASH. Here, IPMK is linked to fatty liver disease.